Pub. Date : 2018 Oct 1
PMID : 29959144
1 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | Treatment of established lines and primary ovarian cancer cultures with Src and MEK inhibitors saracatinib and selumetinib, respectively, showed target kinase inhibition and synergistic induction of apoptosis and cell-cycle arrest in vitro, and tumor inhibition in xenografts. | saracatinib | SRC proto-oncogene, non-receptor tyrosine kinase | Homo sapiens |